Geron Appoints Vice President, Human Resources
20 juin 2019 16h27 HE
|
Geron Corporation
MENLO PARK, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the appointment of Shannon Odam as Vice President, Human Resources. Ms. Odam joins other...
Geron Reports Two Imetelstat Data Presentations at European Hematology Association Annual Congress
17 juin 2019 08h20 HE
|
Geron Corporation
Updated 8-week RBC-TI rate for the Phase 2 portion of IMerge increased to 42%, from 37% in December 2018Updated 24-week RBC-TI rate for the Phase 2 portion of IMerge increased to 29%, from 26% in...
Geron to Webcast KOL Event on June 25, 2019
10 juin 2019 16h45 HE
|
Geron Corporation
MENLO PARK, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that the Company will webcast an event on June 25, 2019, featuring key opinion leaders (KOLs)...
Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association
10 juin 2019 07h30 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 10, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics Announces Presentations at Three Upcoming Conferences
28 mai 2019 07h30 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 28, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Geron Announces Two Presentations on Imetelstat at Upcoming European Hematology Association Annual Congress
16 mai 2019 09h05 HE
|
Geron Corporation
MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that two abstracts containing clinical data and analyses related to imetelstat, the Company’s...
Geron Continues to Build Senior Leadership of Its Development Team
16 mai 2019 06h00 HE
|
Geron Corporation
MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it is continuing to build the senior leadership of its development team with the addition...
Onconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial Results
14 mai 2019 07h30 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...
Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China
13 mai 2019 07h30 HE
|
Onconova Therapeutics, Inc.
Onconova to Receive $4 Million Upfront, including $2 Million Fee and $2 Million for Onconova Shares Purchased at a Premium, Plus up to $45.5 Million in Regulatory and Sales Milestones for Rigosertib...
Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2019 Financial Results
07 mai 2019 07h30 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 07, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...